- Home
- CMPX vs FSP Comparison
CMPX vs FSP Comparison
Compare CMPX & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- FSP
- Stock Information
- Founded
- CMPX 2014
- FSP 1981
- Country
- CMPX United States
- FSP United States
- Employees
- CMPX N/A
- FSP N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- FSP Real Estate Investment Trusts
- Sector
- CMPX Health Care
- FSP Real Estate
- Exchange
- CMPX Nasdaq
- FSP Nasdaq
- Market Cap
- CMPX 217.4M
- FSP 160.3M
- IPO Year
- CMPX N/A
- FSP N/A
- Fundamental
- Price
- CMPX $1.43
- FSP $1.64
- Analyst Decision
- CMPX Strong Buy
- FSP
- Analyst Count
- CMPX 2
- FSP 0
- Target Price
- CMPX $9.00
- FSP N/A
- AVG Volume (30 Days)
- CMPX 429.9K
- FSP 285.6K
- Earning Date
- CMPX 08-12-2024
- FSP 11-05-2024
- Dividend Yield
- CMPX N/A
- FSP 2.44%
- EPS Growth
- CMPX N/A
- FSP N/A
- EPS
- CMPX N/A
- FSP N/A
- Revenue
- CMPX $850,000.00
- FSP $133,729,000.00
- Revenue This Year
- CMPX N/A
- FSP N/A
- Revenue Next Year
- CMPX $950.68
- FSP $0.02
- P/E Ratio
- CMPX N/A
- FSP N/A
- Revenue Growth
- CMPX N/A
- FSP N/A
- 52 Week Low
- CMPX $0.77
- FSP $1.47
- 52 Week High
- CMPX $2.34
- FSP $2.72
- Technical
- Relative Strength Index (RSI)
- CMPX 60.03
- FSP 47.15
- Support Level
- CMPX $1.19
- FSP $1.70
- Resistance Level
- CMPX $1.61
- FSP $1.78
- Average True Range (ATR)
- CMPX 0.10
- FSP 0.07
- MACD
- CMPX 0.02
- FSP 0.00
- Stochastic Oscillator
- CMPX 43.34
- FSP 30.77
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.